Is moderate intestinal metaplasia in chronic atrophic gastritis severe?
Apr 03, 2023
Source: Cainiu Health
Dr. Zhou Chao
Introduction
Moderate intestinal metaplasia in chronic atrophic gastritis is relatively serious and requires prompt medical evaluation and appropriate treatment. It is commonly associated with factors such as gastric mucosal injury, duodenogastric reflux, and Helicobacter pylori infection, which may repeatedly damage the gastric mucosal epithelium, leading to glandular atrophy. Treatment with quadruple therapy should be conducted under a physician's guidance.
Moderate intestinal metaplasia in chronic atrophic gastritis is relatively serious and requires timely medical evaluation and targeted treatment. Specific analysis is as follows:
Moderate intestinal metaplasia in chronic atrophic gastritis is usually associated with factors such as gastric mucosal injury, duodenogastric reflux, and Helicobacter pylori infection. These factors may repeatedly damage the gastric mucosal epithelium, leading to glandular atrophy. Treatment under a doctor's guidance—such as quadruple therapy including lansoprazole enteric-coated tablets, citric acid bismuth potassium tablets, and tinidazole tablets—can help promote recovery. If not treated promptly, moderate intestinal metaplasia may progress and increase the risk of malignant transformation. Immediate further examination at a hospital is necessary, and appropriate therapeutic measures should be taken under medical supervision.
In addition, it is important to develop healthy dietary habits. Patients should consume easily digestible foods and avoid excessively spicy or hard foods. If physical condition permits, engaging in appropriate outdoor exercise can enhance immunity and aid in recovery.
